Cite
HARVARD Citation
Hsu, Y. et al. (2021). Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. Lancet infectious diseases. 21 (6), pp. 823-833. [Online].